Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Demeter

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2010
HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapyViktor von Wyl, Maryam Ehteshami, Lisa M Demeter, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|January 16, 2004
Drug resistance mutations in HIV-1Victoria A Johnson, Françoise Brun-Vézinet, Bonaventura Clotet, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|November 2, 2004
Update of the drug resistance mutations in HIV-1: 2004Victoria A Johnson, Francoise Brun-Vézinet, Bonaventura Clotet, et al.
The Journal of Infectious Diseases|February 23, 2010
Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptaseViktor von Wyl, Maryam Ehteshami, Jori Symons, et al.
The Journal of Infectious Diseases|December 17, 2009
No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapyRajesh T Gandhi, Ronald J Bosch, Evgenia Aga, et al.
Antiviral Therapy|February 6, 2004
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavirScott M Hammer, Roland Bassett, Kathleen E Squires, et al.
Annals of Internal Medicine|December 4, 2001
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320L M Demeter, M D Hughes, R W Coombs, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|July 24, 2003
Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines PanelMartin S Hirsch, Françoise Brun-Vézinet, Bonaventura Clotet, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|July 3, 2003
Drug resistance mutations in HIV-1Richard T D'Aquila, Jonathan M Schapiro, Françoise Brun-Vézinet, et al.
HIV Clinical Trials|January 18, 2011
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimenScott M Hammer, Heather Ribaudo, Roland Bassett, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2010
HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapyViktor von Wyl, Maryam Ehteshami, Lisa M Demeter, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|January 16, 2004
Drug resistance mutations in HIV-1Victoria A Johnson, Françoise Brun-Vézinet, Bonaventura Clotet, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|November 2, 2004
Update of the drug resistance mutations in HIV-1: 2004Victoria A Johnson, Francoise Brun-Vézinet, Bonaventura Clotet, et al.
The Journal of Infectious Diseases|February 23, 2010
Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptaseViktor von Wyl, Maryam Ehteshami, Jori Symons, et al.
The Journal of Infectious Diseases|December 17, 2009
No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapyRajesh T Gandhi, Ronald J Bosch, Evgenia Aga, et al.
Antiviral Therapy|February 6, 2004
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavirScott M Hammer, Roland Bassett, Kathleen E Squires, et al.
Annals of Internal Medicine|December 4, 2001
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320L M Demeter, M D Hughes, R W Coombs, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|July 24, 2003
Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines PanelMartin S Hirsch, Françoise Brun-Vézinet, Bonaventura Clotet, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|July 3, 2003
Drug resistance mutations in HIV-1Richard T D'Aquila, Jonathan M Schapiro, Françoise Brun-Vézinet, et al.
HIV Clinical Trials|January 18, 2011
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimenScott M Hammer, Heather Ribaudo, Roland Bassett, et al.
Pageof 9